AbCellera Biologics
D

ABCL

11.885
USD
0.78
(6.98%)
Post Trading·11.890USD+0.005(+0.04%)
Last updated: · Delayed 15 min
Volume
62,041
EPS
-1
Div Yield
-
P/E
-22
Market Cap
3,851,302,909
Overview
Related Instruments
AAPL
AAPL
D
Apple
342.36
-1.92(-0.56%)
343.00+0.64(+0.19%)
AMZN
AMZN
D
Amazon.com
259.35
-1.16(-0.45%)
259.88+0.53(+0.20%)
BABA
BABA
D
Alibaba Group Holding
109.460
1.360(1.26%)
109.290-0.170(-0.16%)
FB
FB
D
ProShares S&P 500 Dynamic Buffer ETF
44.095
0.028(0.06%)
44.0950.000(0.00%)
GOOGL
GOOGL
D
Alphabet
284.72
2.14(0.76%)
285.50+0.79(+0.28%)
MSFT
MSFT
D
Microsoft
530.70
-5.58(-1.04%)
531.55+0.85(+0.16%)
NFLX
NFLX
D
Netflix
63.390
-2.150(-3.28%)
63.430+0.040(+0.06%)
TSLA
TSLA
D
Tesla
358.17
14.73(4.29%)
359.17+1.00(+0.28%)
V
V
D
VISA
422.68
0.14(0.03%)
422.15-0.53(-0.13%)
More

Title: AbCellera Biologics

Sector: Healthcare
Industry: Biotechnology
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Common questions about AbCellera Biologics stock

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.